If you have spent any time researching emerging metabolic peptides online, you have probably encountered several different terms that appear to describe the same type of compound: Retatrutide. LY3437943. GLP-3 RT. GLP3-RT. RT. For researchers, this terminology can create legitimate confusion. Is GLP3-RT a different peptide? Is it simply another name for retatrutide? Is “RT60” […]

🧬 What Is Tesamorelin? Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that has been extensively studied for its effects on the growth hormone (GH) axis and body composition. Unlike growth hormone itself, Tesamorelin does not directly provide exogenous GH. Instead, it is designed to interact with the body’s GHRH receptor system, stimulating

Retatrutide expanded access has opened by Eli Lilly. Retatrutide (LY3437943) has been one of the most closely watched investigational molecules in metabolic research, and August 2026 brought another significant development. Eli Lilly has announced a limited pre-approval expanded-access pathway for retatrutide, allowing a small number of eligible patients with severe, refractory obesity and serious obesity-related

KLOW peptide blend has become an increasingly interesting subject in peptide research because it combines four compounds with distinctly different areas of biological investigation: BPC-157, TB-500, GHK-Cu, and KPV. Rather than focusing on one signaling pathway, KLOW brings together compounds that researchers study in connection with tissue repair, extracellular matrix biology, cellular migration, angiogenic signaling,

A Comprehensive Pillar Resource for Researchers Retatrutide (LY3437943) represents one of the most significant advances in metabolic peptide research of the past decade. As a first-in-class triple hormone receptor agonist targeting the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors, it has produced some of the highest average weight reductions ever recorded in

Cagrilintide has emerged as one of the most closely watched investigational peptides in metabolic and obesity research. Unlike traditional GLP-1 receptor agonists, cagrilintide is a long-acting amylin analogue designed to interact with the amylin receptor system. Researchers are investigating how this pathway influences appetite, satiety, food intake, body weight, and metabolic regulation. Interest in cagrilintide

Every second, billions of chemical reactions occur inside your body’s cells. While these reactions generate the energy needed to sustain life, they also produce unstable molecules known as reactive oxygen species (ROS). Without protective systems in place, these molecules can damage proteins, DNA, and cellular membranes. One of the body’s most important defense mechanisms against

A Deep Dive into Cell Signaling, Receptors, and Molecular Messengers 🧬 Inside the Cell: How Peptides Trigger Cellular Communication We are going to talk about how peptides work. Every second, trillions of cells throughout the human body are exchanging information. Unlike spoken language, these microscopic conversations occur through molecules, receptors, electrical signals, and intricate biochemical

Few discoveries in peptide science have generated as much excitement as MOTS-C. Unlike many peptides that originate from the nucleus of a cell, MOTS-C is one of a small group of mitochondrial-derived peptides (MDPs) encoded by mitochondrial DNA. This unique origin has sparked intense scientific interest because mitochondria play a central role in energy production,

Tesamorelin Research Guide: Mechanism, Studies, and Laboratory Applications Among the many peptides studied in endocrine and metabolic research, Tesamorelin stands out because it is one of the few with an extensive body of published human research. Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Rather than supplying growth hormone directly, it stimulates the